Primary Site >> Stomach Cancer
Gene >> ABCC2
| 1. | |||||||||||
| Journal: | Suppl Tumori. 2003 Sep-Oct;2(5):S19-22. | ||||||||||
| Title: | Pharmacogenetics of stomach cancer. | ||||||||||
| Author: | Toffoli, Giuseppe|Cecchin, Erika | ||||||||||
| PMID: | 12914384 | ||||||||||
| 2. | |||||||||||
| Journal: | Mol Ther. 2005 Apr;11(4):508-22. | ||||||||||
| Title: | Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP. | ||||||||||
| Author: | Kowalski, Petra|Surowiak, Pawel|Lage, Hermann | ||||||||||
| PMID: | 15771954 | ||||||||||
| 3. | |||||||||||
| Journal: | Oncol Rep. 2009 Jul;22(1):73-80. | ||||||||||
| Title: | The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells. | ||||||||||
| Author: | Chen, Xi|Zhang, Mu|Liu, Lian-Xin | ||||||||||
| PMID: | 19513507 | ||||||||||
| 4. | |||||||||||
| Journal: | Eur J Pharm Sci. 2012 Aug 15;46(5):426-34. | ||||||||||
| Title: | The effect of radixin knockdown on the expression and efflux function of MRP2 in SGC-7901 cells. | ||||||||||
| Author: | He, Xiao-Jie|Wang, Wei-Rong|Zhang, Yun|Yang, Qing | ||||||||||
| PMID: | 22469515 | ||||||||||
| 5. | |||||||||||
| Journal: | Oncol Rep. 2016 May;35(5):2576-82. | ||||||||||
| Title: | Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma. | ||||||||||
| Author: | Kataoka, Junro|Shiraha, Hidenori|Horiguchi, Shigeru|Sawahara, Hiroaki|Uchida, Daisuke|Nagahara, Teruya|Iwamuro, Masaya|Morimoto, Hiroki|Takeuchi, Yasuto|Kuwaki, Kenji|Onishi, Hideki|Nakamura, Shinichiro|Takaki, Akinobu|Nouso, Kazuhiro|Yagi, Takahito|Yamam | ||||||||||
| PMID: | 26985715 | ||||||||||
| 6. | |||||||||||
| Journal: | Oncotarget. 2016 Aug 23;7(34):55449-55457. | ||||||||||
| Title: | ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients. | ||||||||||
| Author: | Li, Ziyu|Xing, Xiaofang|Shan, Fei|Li, Shuangxi|Li, Zhongwu|Xiao, Aitang|Xing, Zhaodong|Xue, Kan|Li, Zhemin|Hu, Ying|Jia, Yongning|Miao, Rulin|Zhang, Lianhai|Bu, Zhaode|Wu, Aiwen|Ji, Jiafu | ||||||||||
| PMID: | 27487151 | ||||||||||
| 7. | |||||||||||
| Journal: | Int J Cancer. 2017 Oct 15;141(8):1682-1689. | ||||||||||
| Title: | DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance. | ||||||||||
| Author: | Takegawa, Naoki|Nonagase, Yoshikane|Yonesaka, Kimio|Sakai, Kazuko|Maenishi, Osamu|Ogitani, Yusuke|Tamura, Takao|Nishio, Kazuto|Nakagawa, Kazuhiko|Tsurutani, Junji | ||||||||||
| PMID: | 28677116 | ||||||||||
| 8. | |||||||||||
| Journal: | J Cell Biochem. 2018 Apr;119(4):3608-3617. | ||||||||||
| Title: | Combination of TNM staging and pathway based risk score models in patients with gastric cancer. | ||||||||||
| Author: | Zhou, Yang-Yang|Kang, Yan-Ting|Chen, Chao|Xu, Fan-Fan|Wang, Hao-Nan|Jin, Rong | ||||||||||
| PMID: | 29231991 | ||||||||||
| 9. | |||||||||||
| Journal: | Oncol Rep. 2018 Oct;40(4):2334-2342. | ||||||||||
| Title: | Conditioned medium mimicking the tumor microenvironment augments chemotherapeutic resistance via ataxiatelangiectasia mutated and nuclear factorkappaB pathways in gastric cancer cells. | ||||||||||
| Author: | Zhuang, Xinguo|Li, Xun|Zhang, Jiaqin|Hu, Yi|Hu, Bin|Shi, Yi|Sun, Yao|Hong, Guolin | ||||||||||
| PMID: | 30106453 | ||||||||||
| 10. | |||||||||||
| Journal: | Int J Oncol. 2018 Sep 11. | ||||||||||
| Title: | Y-box binding protein-1 and STAT3 independently regulate ATP-binding cassette transporters in the chemoresistance of gastric cancer cells. | ||||||||||
| Author: | Chua, Pei Jou|Lim, Jia Pei|Guo, Tian Tian|Khanna, Puja|Hu, Qidong|Bay, Boon Huat|Baeg, Gyeong Hun | ||||||||||
| PMID: | 30221675 | ||||||||||